FDA Airs Safety Concerns About Merck Insomnia Drug
The U.S. Food and Drug Administration on Monday released a clinical study of Merck & Co. Inc. insomnia drug suvorexant revealing some troubling side effects, including suicidal behavior and impaired driving...To view the full article, register now.
Already a subscriber? Click here to view full article